Genomic News and Research

RSS
Novel device may help restore total eye function

Novel device may help restore total eye function

Discovery of protein function could be important for future chemotherapy treatment

Discovery of protein function could be important for future chemotherapy treatment

Specific genetic target could help explain the variation in COVID-19 effects

Specific genetic target could help explain the variation in COVID-19 effects

Oral hormone therapy significantly alters the metabolome of postmenopausal women

Oral hormone therapy significantly alters the metabolome of postmenopausal women

A new approach to identify genomic regions in our brain that contribute to make us human

A new approach to identify genomic regions in our brain that contribute to make us human

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

SARS-CoV-2 unique deletion variants found in clinical specimens

SARS-CoV-2 unique deletion variants found in clinical specimens

Genomic and immune indicators can help identify prostate cancer patients at high risk of lethal outcomes

Genomic and immune indicators can help identify prostate cancer patients at high risk of lethal outcomes

FDA approves first IGA in GalSafe pigs for human food, promising therapeutic uses

FDA approves first IGA in GalSafe pigs for human food, promising therapeutic uses

Children with cancer do not appear to be at increased risk of severe COVID-19 infection

Children with cancer do not appear to be at increased risk of severe COVID-19 infection

Extensive genomic data can improve breast cancer risk assessment

Extensive genomic data can improve breast cancer risk assessment

Emergence of resistant SARS-CoV-2 variant in immunocompromised patient following therapeutic antibody use

Emergence of resistant SARS-CoV-2 variant in immunocompromised patient following therapeutic antibody use

Prior T cell immunity to SARS-CoV-2 unlikely to be the result of seasonal coronavirus infection

Prior T cell immunity to SARS-CoV-2 unlikely to be the result of seasonal coronavirus infection

D614G mutation promotes lysosomal trafficking of SARS-CoV-2 spike protein

D614G mutation promotes lysosomal trafficking of SARS-CoV-2 spike protein

RNA editing within host linked to SARS-CoV-2 variants

RNA editing within host linked to SARS-CoV-2 variants

Scientists get closer to finding the genes for maleness in weeds

Scientists get closer to finding the genes for maleness in weeds

Study shows how coronavirus uses spike proteins to infiltrate cells of different animals

Study shows how coronavirus uses spike proteins to infiltrate cells of different animals

Data confirms early cases of SARS-CoV-2 in Boston area

Data confirms early cases of SARS-CoV-2 in Boston area

IGC researchers receive three out of six European Research Council grants

IGC researchers receive three out of six European Research Council grants

Hematoxylin compounds can selectively kill CALR mutant cancer cells

Hematoxylin compounds can selectively kill CALR mutant cancer cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.